Skip to content
OpenCapital
Get started

Chemed CHE Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

GHC
Graham HoldingsGHC
——
HCA Healthcare logo
HCA HealthcareHCA
——

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's software and technology licenses, net?
Chemed (CHE) reported software and technology licenses, net of $8.73M in Q1 2026.
How has Chemed's software and technology licenses, net changed year-over-year?
Chemed's software and technology licenses, net increased by 2.9% year-over-year, from $8.48M to $8.73M.
What is the long-term trend for Chemed's software and technology licenses, net?
Over 5 years (2020 to 2025), Chemed's software and technology licenses, net has grown at a 2.2% compound annual growth rate (CAGR), from $8.9M to $9.9M.